"Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 5868-5877

  Lan, Yuk Yuen ^a,b   Wang, Zhiliang ^a   Raimondi, Giorgio ^a   Wu, Wenhan ^a   Colvin, Bridget L ^a   De Creus, An ^a   Thomson, Angus W ^a,b,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ALLOANTIGEN; B7 ANTIGEN; B7 H1 ANTIGEN; BINDING PROTEIN; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALTERNATIVELY ACTIVATED DENDRITIC CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT STRAIN;

EID: 33750339165     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.5868     Document Type: Article

References (61)

1. Steinman, R. M., D. Hawiger, K. Liu, L. Bonifaz, D. Bonnyay, K. Mahnke, T. Iyoda, J. Ravetch, M. Dhodapkar, K. Inaba, and M. Nussenzweig. 2003. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. NY Acad. Sci. 987: 15-25.
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
3. Morelli, A. E., and A. W. Thomson. 2003. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196: 125-146.
4. - induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60: 1539-1545.
5. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62: 659-665.
6. Lutz, M. B., R. M. Suri, M. Niimi, A. L. Ogilvie, N. A. Kukutsch, S. Rossner, G. Schuler, and J. M. Austyn. 2000. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30: 1813-1822.
7. Hackstein, H., A. E. Morelli, A. T. Larregina, R. W. Ganster, G. D. Papworth, A. J. Logar, S. C. Watkins, L. D. Falo, and A. W. Thomson. 2001. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J. Immunol. 166: 7053-7062.
8. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411.
9. 3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164: 4443-4451.
10. Matyszak, M. K., S. Citterio, M. Rescigno, and P. Ricciardi-Castagnoli. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30: 1233-1232.
11. Lee, J. I., R. W. Ganster, D. A. Geller, G. J. Burckart, A. W. Thomson, and L. Lu. 1999. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor κB. Transplantation 68: 1255-1263.
12. Hackstein, H., T. Taner, A. F. Zahorchak, A. E. Morelli, A. J. Logar, A. Gessner, and A. W. Thomson. 2003. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101: 4457-4463.
13. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167: 1945-1953.
14. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34.
15. Mirenda, V., I. Berton, J. Read, T. Cook, J. Smith, A. Dorling, and R. I. Lechler. 2004. Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 15: 987-997.
16. Taner, T., H. Hackstein, Z. Wang, A. E. Morelli, and A. W. Thomson. 2005. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 5: 228-236.
17. Moore, K. W., R. de Waal Malefytqq, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Anna. Rev. Immunol. 19: 683-765.
18. De Smedt, T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27: 1229-1235.
19. Corinti, S., C. Albanesi, A. La Sala, S. Pastore, and G. Girolomoni. 2001. Regulatory activity of automne IL-10 on dendritic cell functions. J. Immunol. 166: 4312-4318.
20. + dendritic cells is modulated under serum-free conditions by exogenously added IFN-γ and endogenously produced IL-10. Eur. J. Immunol. 31: 3773-3781.
21. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159: 4772-4780.
22. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99: 2468-2476.
23. Takayama, T., Y. Nishioka, L. Lu, M. T. Lotze, H. Tahara, and A. W. Thomson. 1998. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66: 1567-1574.
24. + Tr cells. Blood 105: 1162-1169.
25. Christ, M., N. L. McCartney-Francis, A. B. Kulkarni, J. M. Ward, D. E. Mizel, C. L. Mackall, R. E. Gress, K. L. Hines, H. Tian, and S. Karlsson. 1994. Immune dysregulation in TGF-β1-deficient mice. J. Immunol. 153: 1936-1946.
26. Yamaguchi, Y., H. Tsumura, M. Miwa, and K. Inaba. 1997. Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15: 144-153.
27. Riedl, E., H. Strobl, O. Majdic, and W. Knapp. 1997. TGF-β1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J. Immunol. 158: 1591-1597.
28. + regulatory T cells from human peripheral blood. J. Immunol. 166: 7282-7289.
29. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
30. + regulatory T cell proliferation. J. Exp. Med. 202: 919-929.
31. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β. J. Immunol. 163: 3684-3691.
32. Lee, W. C., S. Qiani, Y. Wan, W. Li, Z. Xing, J. Gauldie, J. J. Fung, A. W. Thomson, and L. Lu. 2000. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection. Immunology 101: 233-241.
33. Takayama, T., K. Kaneko, A. E. Morelli, W. Li, H. Tahara, and A. W. Thomson. 2002. Retroviral delivery of transforming growth factor-β1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival. Transplantation 74: 112-119.
34. Sato, K., N. Yamashita, M. Baba, and T. Matsuyama. 2003. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 101: 3581-3589.
35. Sato, K., N. Yamashita, N. Yamashita, M. Baba, and T. Matsuyama. 2003. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18: 367-379.
36. Fujita, S., K. Seino, K. Sato, Y. Sato, K. Eizumi, N. Yamashita, M. Taniguchi, and K. Sato. 2006. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107: 3656-3664.
37. Morelli, A. E., A. F. Zahorchak, A. T. Larregina, B. L. Colvin, A. J. Logar, T. Takayama, L. D. Falo, and A. W. Thomson. 2001. Cytokine production by mouse dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 98: 1512-1523.
38. Lan, Y. Y., A. De Creus, B. L. Colvin, M. Abe, V. Brinkmann, P. T. Coates, and A. W. Thomson. 2005. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am. J. Transplant. 5: 2649-2659.
39. + resting regulatory T cells from activated T cells. J. Immunol. 176: 2808-2816.
40. - dendritic cells and their in vivo trafficking. J. Leukocyte Biol. 75: 275-285.
41. Colvin, B. L., Z. Wang, H. Nakano, W. Wu, T. Kakiuchi, R. L. Fairchild, and A. W. Thomson. 2005. CXCL9 antagonism further extends prolonged cardiac allograft survival in CCL19/CCL21-deficient mice. Am. J. Transplant. 5: 2104-2113.
42. + dendritic cells prolong the survival of vascularized heart allografts. J. Immunol. 168: 143-154.
43. McCartney-Francis, N., W. Jin, and S. M. Wahl. 2004. Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-β1 signaling pathway. J. Immunol. 172: 3814-3821.
44. Mou, H. B., M. F. Lin, H. Cen, J. Yu, and X. J. Meng. 2004. TGF-β1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression. J. Zhejiang Univ. Sci. 5: 1239-1244.
45. Abe, M., Z. Wang, A. de Creus, and A. W. Thomson. 2005. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5: 1808-1819.
46. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
47. Roelen, D. L., D. H. Schuurhuis, D. E. van den Boogaardt, K. Koekkoek, P. P. van Miert, J. J. van Schip, S. Laban, D. Rea, C. J. Melief, R. Offringa, et al. 2003. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76: 1608-1615.
48. Lu, L., W. Li, F. Fu, F. G. Chambers, S. Qian, J. J. Fung, and A. W. Thomson. 1997. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64: 1808-1815.
49. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
50. Naiki, Y., K. S. Michelsen, W. Zhang, S. Chen, T. M. Doherty, and M. Arditi. 2005. Transforming growth factor-β differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J. Biol. Chem. 280: 5491-5495.
51. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347.
52. Aramaki, O., N. Shirasugi, T. Takayama, M. Shimazu, M. Kitajima, Y. Ikeda, M. Azuma, K. Okumura, H. Yagita, and M. Niimi. 2004. Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation 77: 6-12.
53. Aicher, A., M. Hayden-Ledbetter, W. A. Brady, A. Pezzutto, G. Richter, D. Magaletti, S. Buckwalter, J. A. Ledbetter, and E. A. Clark. 2000. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164: 4689-4696.
54. Kitade, H., M. Kawai, O. Rutgeerts, W. Landuyt, M. Waer, C. Mathieu, and J. Pirenne. 2005. Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J. Immunol. 175: 4963-4970.
55. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
56. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
57. Fujita, S., K. I. Seino, K. Sato, Y. Sato, K. Eizumi, N. Yamashita, M. Taniguchi, and K. Sato. 2006. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107: 3656-3664.
58. Emmanouilidis, N., Z. Guo, Y. Dong, M. Newton-West, A. B. Adams, E. D. Lee, J. Wang, T. C. Pearson, C. P. Larsen, and K. A. Newell. 2006. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells. Transplantation 81: 455-462.
59. Bonham, C. A., L. Peng, X. Liang, Z. Chen, L. Wang, L. Ma, H. Hackstein, P. D. Robbins, A. W. Thomson, J. J. Fung, et al. 2002. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol. 169: 3382-3391.
60. Niimi, M., N. Shirasugi, Y. Ikeda, S. Kan, H. Takami, and K. Hamano. 2001. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway. Transplantation 72: 1556-1562.
61. Wang, Z., A. E. Morelli, H. Hackstein, K. Kaneko, and A. W. Thomson. 2003. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb. Transplantation 76: 562-571.